Literature DB >> 12153576

The proximal cis-acting elements Sp1, Sp3 and E2F regulate mouse mer gene transcription in Sertoli cells.

Connie C S Wong1, Will M Lee.   

Abstract

Mer belongs to the Tyro 3 family of receptor tyrosine kinases (RTKs). Together with Axl and Rse, the three RTKs are believed to play important functional roles in the male gonads because gene knockout male mice lacking all of these receptors are infertile. In the present study, postnatal expression of Axl and Rse in mouse testes decreased during maturation while expression of Mer increased age-dependently during testicular development. To investigate the transcriptional regulation of gene expression in the testis, a approximately 1.5 kb fragment of the 5' flanking sequence of Mer was isolated. The sequence lacks a typical TATA or CAAT box. 5' RACE revealed that the putative major transcriptional start site of Mer is located at +102 bp upstream of the translation initiation site. Using transient transfections of luciferase reporter constructs driven by various lengths of the 5' flanking sequence, the gene segment -321/+126 showed the highest transcriptional activity in a mouse Sertoli cell line (TM4). DNAase I footprinting experiments revealed four footprints within the region from -321 to -26, including three binding sites for the transcriptional factor Specificity protein 1 (Sp1) and one for an unknown transcriptional factor. Electrophoretic mobility shift assay (EMSA), supershift assay, mutation studies and cotransfection demonstrated that those Sp1 cis-acting motifs interacted either with Sp1 or Sp1/Sp3, depending on location and the nearby nucleotide sequences. An E2F binding site which down-regulates Mer transcription, as revealed by EMSA, deletion and mutation studies, was identified downstream in the proximity of the promoter. Taking all of these data together, the study has demonstrated that Sp1, Sp3, E2F and probably another unknown transcriptional factor play a critical role in regulating the proximal promoter activities of Mer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153576     DOI: 10.1046/j.1432-1033.2002.03092.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  TAM receptors in leukemia: expression, signaling, and therapeutic implications.

Authors:  Luis Brandão; Justine Migdall-Wilson; Kristen Eisenman; Douglas K Graham
Journal:  Crit Rev Oncog       Date:  2011

2.  Research resource: the dynamic transcriptional profile of sertoli cells during the progression of spermatogenesis.

Authors:  Céline Zimmermann; Isabelle Stévant; Christelle Borel; Béatrice Conne; Jean-Luc Pitetti; Pierre Calvel; Henrik Kaessmann; Bernard Jégou; Frédéric Chalmel; Serge Nef
Journal:  Mol Endocrinol       Date:  2015-02-24

Review 3.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

4.  Specificity protein-1 and -3 trans-activate the ovine placental lactogen gene promoter.

Authors:  K M Jeckel; S W Limesand; R V Anthony
Journal:  Mol Cell Endocrinol       Date:  2009-04-21       Impact factor: 4.102

Review 5.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

6.  Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders.

Authors:  Zofia Blach-Olszewska; Jerzy Leszek
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.